Literature DB >> 10962338

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.

A Magklara1, A Scorilas, C Stephan, G O Kristiansen, S Hauptmann, K Jung, E P Diamandis.   

Abstract

OBJECTIVES: To study quantitatively the relative expression of human glandular kallikrein 2 (hK2) and prostate-specific antigen (PSA) in paired (from the same patient) cancerous and noncancerous prostatic tissue to evaluate whether these proteins are overexpressed or underexpressed in cancer.
METHODS: We studied 14 patients who underwent radical retropubic prostatectomy for prostate cancer. Cancerous and adjacent normal tissues were excised and then extracted to prepare cytosolic extracts. The extracts were analyzed for total protein, and for hK2 and PSA using sensitive and specific immunofluorometric procedures.
RESULTS: PSA was present in the prostatic extracts at about 50 to 100 times higher amounts than hK2. The correlation between PSA and hK2 values was good. Both prostate kallikreins were expressed more in noncancerous than in cancerous prostatic tissue.
CONCLUSIONS: Our results demonstrated that both PSA and hK2 are down-regulated in prostate cancer compared with noncancerous tissue. The degree of down-regulation was higher for PSA than for hK2. The mechanism and physiologic consequences of this down-regulation are unknown.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962338     DOI: 10.1016/s0090-4295(00)00621-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  12 in total

1.  Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities.

Authors:  Kailash C Chadha; Bindukumar B Nair; Srikant Chakravarthi; Rita Zhou; Alejandro Godoy; James L Mohler; Ravikumar Aalinkeel; Stanley A Schwartz; Gary J Smith
Journal:  Prostate       Date:  2011-03-28       Impact factor: 4.104

2.  Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation.

Authors:  Naoki Terada; Takumi Shiraishi; Yu Zeng; Koh-Meng Aw-Yong; Steven M Mooney; Zhi Liu; Sayuri Takahashi; Jun Luo; Shawn E Lupold; Prakash Kulkarni; Robert H Getzenberg
Journal:  J Cell Biochem       Date:  2014-09       Impact factor: 4.429

3.  The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.

Authors:  Christopher Kim; Xiaofeng Bi; Dongsheng Pan; Yingtai Chen; Tobias Carling; Shuangge Ma; Robert Udelsman; Yawei Zhang
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

4.  Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.

Authors:  A Ylikoski; M Karp; K Pettersson; H Lilja; T Lövgren
Journal:  J Mol Diagn       Date:  2001-08       Impact factor: 5.568

5.  Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer.

Authors:  Matthew D Schmitz; Gilbert D A Padula; Patrick Y Chun; Alan T Davis
Journal:  Radiat Oncol       Date:  2010-09-16       Impact factor: 3.481

6.  Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice.

Authors:  Leonard S Marks; David G Bostwick
Journal:  Rev Urol       Date:  2008

7.  Thiophilic-interaction chromatography of enzymatically active tissue prostate-specific antigen (T-PSA) and its modulation by zinc ions.

Authors:  A K Satheesh Babu; M A Vijayalakshmi; Gary J Smith; Kailash C Chadha
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-04       Impact factor: 3.205

8.  Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth.

Authors:  B Bindukumar; Stanley A Schwartz; Madhavan P N Nair; Ravikumar Aalinkeel; Elzbieta Kawinski; Kailash C Chadha
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

9.  Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.

Authors:  A Scorilas; A Karameris; N Arnogiannaki; A Ardavanis; P Bassilopoulos; T Trangas; M Talieri
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

10.  Progression of prostate cancer despite an extremely low serum level of prostate-specific antigen.

Authors:  Dong Kil Lee; Jeong Hyun Park; Jae Han Kim; Seung Joon Lee; Moon Ki Jo; Myung Cheol Gil; Kang Hyon Song; Jong Wook Park
Journal:  Korean J Urol       Date:  2010-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.